Pretreatment Circulating HPV16 DNA Viral Load Predicts Risk of Distant Metastasis in Patients with HPV16-Positive Oropharyngeal Cancer (original) (raw)

HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas

R HERRERO

International Journal of Cancer, 2005

View PDFchevron_right

Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer

Agnieszka Mazurek

Journal of Translational Medicine, 2020

View PDFchevron_right

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study

Margaritis Avgeris

PLOS ONE

View PDFchevron_right

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis

Urszula Kacorzyk

Scientific Reports, 2023

View PDFchevron_right

Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections

Sakshi Tewari

Oral Oncology, 2020

View PDFchevron_right

Viral RNA Patterns and High Viral Load Reliably Define Oropharynx Carcinomas with Active HPV16 Involvement

Gerhard Dyckhoff

Cancer Research, 2012

View PDFchevron_right

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

Mark Weissler

Clinical Cancer Research, 2019

View PDFchevron_right

Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas

Luca Cerritelli

Cancers

View PDFchevron_right

Association of viral load and physical status of HPV-16 with survival of patients with head and neck cancer

Felix Toro

ecancermedicalscience, 2020

View PDFchevron_right

Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma

Agnieszka Mazurek

Head & Neck, 2018

View PDFchevron_right

Human Papillomavirus16 Infection in Advanced Oral Cavity Cancer Patients Is Related to an Increased Risk of Distant Metastases and Poor Survival

Li-Ang Lee

PLOS One, 2012

View PDFchevron_right

Serum antibodies to HPV16 early proteins as biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer

Raphael Viscidi

Cancer prevention research (Philadelphia, Pa.), 2015

View PDFchevron_right

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Steffen Löck

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014

View PDFchevron_right

Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer

RIZWAN ALAM

Oral Oncology, 2017

View PDFchevron_right

Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma

Laurence Walsh

Cancer Science, 2020

View PDFchevron_right

Does HPV type affect outcome in oropharyngeal cancer?

Anthony Nichols

Journal of Otolaryngology - Head and Neck Surgery, 2013

View PDFchevron_right

Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology – A proof-of-concept study

Yassin Hussein

eClinicalMedicine

View PDFchevron_right

High oral HPV16 viral load predicts long-term persistence in HIV-infected and at risk HIV-uninfected individuals

Susheel Reddy

The Journal of infectious diseases, 2015

View PDFchevron_right

Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma

Gerhard Dyckhoff

British Journal of Cancer, 2013

View PDFchevron_right

HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer

Jan Klozar, R. Tachezy, Eva Hamsíková, Eva Hamsikova

European Archives of Oto-Rhino-Laryngology, 2008

View PDFchevron_right

Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection

Rossana López, Fabiano Saggioro, José Eluf-Neto, Marcos Carvalho

Cancer Causes & Control, 2014

View PDFchevron_right

Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study

Rizwan Alam

Oral Oncology, 2015

View PDFchevron_right

hpv in oropharyngeal cancer

Shymaa Elrefaey, M. Ansarin

View PDFchevron_right

Unlocking the Potential of Saliva-Based Test to Detect HPV-16-Driven Oropharyngeal Cancer

Chamindie Punyadeera

Cancers

View PDFchevron_right